Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 30,000 shares at $35.91 ($1.1M) on 2023-08-03, disclosed to the SEC on 2023-08-04.
Open-market sale of $1.1M VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.55 | 13,300 | $473K | 44.3% |
| 2 | $35.55 | 13,300 | $473K | 44.3% |
| 3 | $35.91 | 1,700 | $61K | 5.7% |
| 4 | $35.91 | 1,700 | $61K | 5.7% |
| Total | $35.59 avg | 30,000 | $1.1M | 100% |
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-07-05 | $1.1M | — | Filing → |